Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKinsey
McKesson
Mallinckrodt
Boehringer Ingelheim

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for PF-04447943

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug PF-04447943: Patents, clinical trial progress, indications

PF-04447943 is an investigational drug.

There have been 8 clinical trials for PF-04447943. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2009.

The most common disease conditions in clinical trials are Alzheimer Disease and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for PF-04447943
TitleSponsorPhase
A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult SubjectsPfizerPhase 1
A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer SubjectsPfizerPhase 1
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's DiseasePfizerPhase 1

See all PF-04447943 clinical trials

Clinical Trial Summary for PF-04447943

Top disease conditions for PF-04447943
Top clinical trial sponsors for PF-04447943

See all PF-04447943 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Dow
Colorcon
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.